Arkansas
Arkansas Act 629 of 2023 (SB 358), signed by Gov. Sarah Huckabee Sanders in April 2023, classifies delta-8 THC, delta-9 THC (in intoxicating concentrations), delta-6a, delta-10a, and synthetically produced cannabinoids as Schedule VI controlled substances. Enforcement was blocked by a federal district court injunction from September 2023 until the U.S. Court of Appeals for the Eighth Circuit reversed the injunction on June 24, 2025 in Bio Gen LLC v. Sanders (No. 23-3237). The 8th Circuit held the 2018 Farm Bill does not preempt state authority to ban intoxicating hemp derivatives. SB 533 (2025) added a 1mg total THC per container cap. Arkansas Tobacco Control (a DFA agency) enforces. THCA is a live litigation question — an anticipated separate challenge was flagged at a state House Rules Committee meeting after the 8th Circuit ruling. Medical cannabis operates under Amendment 98 (2016).
Retail channels
- Non-intoxicating hemp CBD, CBN, CBG at general retail: permitted with COA documentation
- Delta-8, delta-10, delta-6a, delta-10a, THC-O, HHC: BANNED as Schedule VI controlled substances since 6/24/2025
- Hemp delta-9 edibles and beverages exceeding 1mg total THC per container: outside compliant definition — treated as controlled substance
- THCA flower: legal question flagged as anticipated litigation by AG's office; Act 629 does not name THCA but broad language covers convertible cannabinoids
- Medical marijuana dispensaries (Amendment 98): separate channel for cardholders
- Online DTC of intoxicating hemp into Arkansas: enforcement risk since June 2025
Statutes & bills cited
- Act 629 (SB 358, 2023) — signed April 2023 by Gov. Sanders; codified at Ark. Code Ann. §§ 20-56-401 et seq.
- Ark. Code Ann. § 20-56-401 et seq. — Consumable Hemp Products; classifies delta-8, delta-10, delta-6a, delta-10a, THC-O, and synthetically converted cannabinoids as Schedule VI
- Ark. Code Ann. § 5-64-215 — Schedule VI controlled substances list (amended by Act 629)
- SB 533 (2025) — 1mg total THC per container cap on hemp products
- Bio Gen LLC v. Sanders, No. 23-3237 (8th Cir. June 24, 2025) — reversed preliminary injunction; upheld Act 629 against Farm Bill preemption challenge
- AK Futures LLC v. Boyd St. Distro, LLC, 35 F.4th 682 (9th Cir. 2022) — contrasting Ninth Circuit precedent; not binding in Eighth Circuit
- Amendment 98 (Arkansas Medical Marijuana Amendment, 2016) — medical cannabis program
- Act 565 (2019) — Arkansas industrial hemp production framework
Arkansas is the country’s clearest example of a state successfully defending a comprehensive intoxicating-hemp ban against Farm Bill preemption challenges. Act 629 of 2023 (originally SB 358), sponsored by Sen. Tyler Dees and signed by Gov. Sarah Huckabee Sanders in April 2023, took two aggressive steps at once. First, it classified as Schedule VI controlled substances the full slate of hemp-derived intoxicants: delta-8 THC, delta-10 THC, delta-6a, delta-10a, and any cannabinoid produced through synthetic chemical conversion from hemp-derived precursors. Second, it changed how the 0.3% delta-9 THC threshold is measured — from dry weight of the plant (federal standard) to concentration in the finished product — closing the loophole that let 5mg or 10mg hemp delta-9 gummies qualify as legal hemp under the Farm Bill’s dry-weight math. Four hemp businesses led by Bio Gen LLC sued in federal court, naming Gov. Sanders, AG Tim Griffin, and 28 prosecuting attorneys as defendants. In September 2023, U.S. District Judge Billy Roy Wilson granted a preliminary injunction blocking enforcement, finding the plaintiffs likely to succeed on Farm Bill preemption grounds and calling parts of Act 629’s language “[confusing] even an exceptionally intelligent reader.” Arkansas hemp-derived intoxicants continued to sell freely under the Farm Bill from September 2023 through July 2025. Then, on June 24, 2025, the U.S. Court of Appeals for the Eighth Circuit reversed in Bio Gen LLC v. Sanders (No. 23-3237). The three-judge panel held the 2018 Farm Bill does not preempt state authority to ban intoxicating hemp derivatives — the Farm Bill’s protection of interstate transport does not require states to permit in-state sales. The panel also dismissed Gov. Sanders and AG Griffin as improper defendants under Ex parte Young, holding neither has “a sufficiently specific method of enforcement” of Act 629 to be sued. Actual enforcement is handled by Arkansas Tobacco Control, a DFA agency, and by county prosecutors. AG Griffin publicly declared enforcement was resuming, giving retailers “a few weeks” to clear inventory. SB 533 (2025) followed by imposing a strict 1mg total THC per container cap — meaning even the narrow category of “compliant” hemp products under Act 629 is capped far below what neighboring states permit. One live question: THCA flower is not explicitly named in Act 629 but Arkansas applies a total-THC interpretation that captures convertible cannabinoids. At a Arkansas House Rules Committee meeting shortly after the Eighth Circuit ruling, an AG’s office attorney indicated a separate legal challenge specific to THCA is anticipated. Arkansas Medical Marijuana Amendment 98 (2016) operates as a separate dispensary-only channel for cardholders, unaffected by Act 629. For the federal cliff on November 12, 2026, Arkansas is one of the least-disrupted major markets — the intoxicating hemp retail market has been effectively gone since July 2025, and Section 781 will formalize what Arkansas has already achieved through Act 629.
Discover more from Cannabis.Wine
Subscribe to get the latest posts sent to your email.
Sources
- Arkansas AG — Griffin statement on 8th Circuit ruling (June 2025) ↗
- Courthouse News — 8th Circuit Bio Gen v. Sanders coverage ↗
- Arkansas Times — Act 629 enforcement analysis Aug 2025 ↗
- CannabisArkansas.org — Act 629 full analysis ↗
- Cannabis Regulations AI — Arkansas Act 629 post-8th-Circuit ↗
- ATLRx — Arkansas THCA + SB 533 2026 ↗
- KARK — AG Griffin June 2025 enforcement announcement ↗
This state summary has not yet been reviewed by counsel. Verify with your attorney before making commercial decisions.